Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9600 posts found.

Insider Interview: Reducing the risk of adverse cardiovascular events

February 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Insider Interview, cardiovascular, heart disease, pharma

Rodrigo Gribble, Vice President Cardiovascular at AstraZeneca, breaks down recently published data from the PEGASUS trial of ticagrelor, a potential …
Feature
david_hallett

AI firm Exscientia appoints COO and Head of Drug Discovery

January 31, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Exscientia, appointment

AI drug discovery firm Exscientia has announced the appointment of Dr David Hallett as its Chief Operating Officer and Head …
Appointment
shutterstock_159488225

Bayer and Orion’s Nubeqa shows off strong overall survival benefit in castration-resistant prostate cancer

January 31, 2020 Medical Communications, Research and Development Bayer, orion, pharma

Bayer and Finnish pharma firm Orion Corporation have announced positive new Phase 3 data for their jointly developed oral androgen …
News
pharmafocus_janfeb_2020_cover

Read the January/February 2020 edition of Pharmafocus online now!

January 30, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, UK, US, brexit, coronavirus, opioid crisis, pharma

Pharmafocus returns for the New Year with its January/February issue, and things have certainly changed since we left. Brexit got …
News
shutterstock_36423250

Spring Bank Pharma shuts down HBV drug development following patient death

January 30, 2020 Research and Development Spring Bank, patient death, pharma

Biopharma firm Spring Bank Pharmaceuticals has revealed it has taken the decision to terminate all further development of inarigivir soproxil …
News

Johnson & Johnson working on coronavirus vaccine

January 30, 2020 Business Services, Research and Development Chinese Coronavirus, Wuhan Coronavirus, Wuhan epidemic, coronavirus

Johnson & Johnson has become the latest pharmaceutical company to begin work on a vaccine for the Chinese coronavirus. They …
News
logo-24-allergan

Allergan opens new Botox plant in Westport

January 29, 2020 Research and Development AbbVie Ireland, Allergan AbbVie, Allergan. Abbvie

Allergan has officially opened a new €145m facility in Westport, Ireland to boost production of Botox. The new building rxpands …
News
janssen_latest_logo_on_sign_closer

Janssen’s Erleada expanded in Europe to cover metastatic hormone-sensitive prostate cancer

January 29, 2020 Research and Development, Sales and Marketing Erleada, Europe, Janssen, pharma

Janssen’s Erleada (apalutamide) has secured expanded authorisation from the European Commission (EC), approving its label to include the treatment of …
News

BioIntelliSense’ BioSticker sensor approved by the FDA

January 29, 2020 Research and Development Biosticker, home care, sensors

BioIntelliSense has secured 510 (k) clearance from the FDA for its biosticker sensor for remote care. The product is an …
News
teva_copy

FDA approves Teva’s Ajovy autoinjector for treatment of migraine

January 29, 2020 Research and Development, Sales and Marketing FDA, Teva, ajovy, migraine, pharma

Israeli pharma firm Teva has revealed that the FDA has chosen to award approval to its autoinjector device for the …
News
british-2746299_960_720

British Airways suspends all flights to mainland China

January 29, 2020 Research and Development British Airways, MERS, Sars, Wuhan Virus, coronavirus, virus

British Airways has ceased all flights to mainland China until 31 January. This comes after the Foreign Office advice against …
News
shutterstock_243110086

Lilly & Incyte’s Olumiant hits main goal in atopic dermatitis

January 28, 2020 Manufacturing and Production, Research and Development Eli Lilly, Olumiant, pharma

Eli Lilly and Incyte have lifted the curtain on new Phase 3 data showing that their oral JAK inhibitor, showing …
News
lynn_taylor_updated_headshot_web

Realising the potential of greater collaboration for women living with cancer

January 27, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Merck KGaA, feature, pharma, women

Following the launch of a new global report, ‘Supporting women with cancer’, Lynn Talyroe, Senior Vice President, Head of Healthcare …
Feature
top_10_image_43

Top Ten most popular articles on Pharmafile.com this week

January 24, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Indian pharmaceutical firms received more than double the amount of warning letters in the first ten months of 2019, compared …
News
janssen_latest_logo_on_sign_closer

European Commission expands Stelara for paediatric moderate to severe plaque psoriasis

January 24, 2020 Research and Development Europe, Janssen, Stelara, pharma

Janssen’s Stelara (ustekinumab) has seen its label expanded in Europe to include the treatment of moderate to severe plaque psoriasis …
News
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026